Harmony Biosciences Holdings, Inc. announced unaudited consolidated earnings results for the second quarter and six months ended June 30, 2021. For the quarter, the company reported net product revenues of $73,821,000 compared to $38,005,000 a year ago. Operating income was $23,312,000 compared to $7,309,000 a year ago. Net income and comprehensive income was $14,117,000 or $0.25 per basic share compared to loss of $27,000 or $1.34 per basic share a year ago. Diluted earnings per share was $0.24 compared to loss of $1.34 a year ago. For the six months, the company reported net product revenues of $133,495,000 compared to $57,845,000 a year ago. Operating income was $37,844,000 compared to loss of $1,154,000 a year ago. Net income and comprehensive income was $21,503,000 or $0.38 per basic share compared to loss of $38,647,000 or $7.63 per basic share a year ago. Diluted earnings per share was $0.37 compared to loss of $7.63 a year ago.